The American College of Cardiology (ACC) will launch two registries to track the outcomes of treatments for atrial fibrillation, the medical society announced today.
The LAAO Registry will capture data on left atrial appendage occlusion procedures to assess real-world procedural indications and outcomes, as well as short- and long-term safety.
The AFib Ablation Registry will assess the prevalence, demographics, acute management, and outcomes of patients undergoing atrial fibrillation ablation procedures. This registry’s data will support the development of evidence-based guidelines and quality metrics for atrial fibrillation treatments that will improve outcomes, according to the ACC.
“With a growing prevalence of atrial fibrillation and growing options for treatment and stroke prevention in AFib patients, the ACC saw a need for real-world data to track and evaluate the use of these new technologies,” said Dr. Kim A. Williams Sr., ACC president.
